Corrigendum to "OVATION-2: A randomized phase I/II study evaluating the safety and efficacy of IMNN-001 (IL-12 gene therapy) with neo/adjuvant chemotherapy in patients newly-diagnosed with advanced epithelial ovarian cancer" [Gynecol Oncol 2025 Jun 197 182-191].
Publication Title
Gynecologic oncology
Document Type
Article
Publication Date
12-1-2025
Keywords
washington; pshmc; spokane; oregon; chiles
Area of Special Interest
Women & Children
Area of Special Interest
Cancer
Specialty/Research Institute
Obstetrics & Gynecology
Specialty/Research Institute
Oncology
DOI
10.1016/j.ygyno.2025.10.031
COinS
